Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
ADI-001
i
Other names:
ADI-001, ADI001, ADI 001
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
(1)
News
Trials
Company:
Adicet Bio
Drug class:
γδ TCR modulator, CD20-targeted CAR-T immunotherapy
Related drugs:
‹
Undisclosed allogeneic Vγ9Vδ2 HER2-TAC T (4)
ACE2016 (2)
ACE1831 (0)
ADI-002 (0)
BTN2A1/3A1-Fc-CD19scFv (0)
CD7-UCAR-γδT cells (0)
CLN-619 (0)
CTM-N2D (0)
ECT204 (0)
ET 019003 (0)
ET-190 (0)
ET140203 (0)
ET1402L1-ARTEMIS T cells (0)
ET206 (0)
GDT002 (0)
Gamma delta T-cells (0)
ICT01 (0)
INB-100 (0)
INB-200 (0)
INB-300 (0)
autologous γδ T lymphocytes (0)
ALEXIS-ISO-1 (0)
LAVA-051 (0)
LYT-210 (0)
NK/γδ T cell-enriched cell therapy (0)
PF-08046052 (0)
QH104 (0)
TAK-012 (0)
UTAA06 (0)
anti-CD19-CAR γδT (0)
AVM0703 (0)
γδT Cell infusion (0)
γδT Cell infusion agent (0)
IMPT-314 (2)
MB-106 (1)
JNJ-4496 (1)
4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR (0)
4SCAR-T (0)
Anti-CD19/CD20/CD22 CAR T-Cells (0)
CAR-20/19-T Cells (0)
CAR-T CD19/CD20/CD22/CD30 (0)
CAR20.19.22 T (0)
CART20 (0)
CBM-C20.1 (0)
CD19/CD20 CAR T-cells (0)
CD20-CART (0)
CD20-CD19 cCAR T cells (0)
ELC-301 (0)
JNJ-9530 (0)
KITE-363 (0)
LCAR-AIO (0)
LY007 (0)
MB-CART20.1 (0)
PBCAR 20A (0)
RG6540 (0)
U16 (0)
UCART20x22 (0)
YTS101 (0)
autologous TriCAR T (0)
bbT369 (0)
multi-CAR-T cell therapy (0)
sequential different B cell antigen-targeted CAR T-cell therapy (0)
MB-CART2019.1 (0)
Undisclosed allogeneic Vγ9Vδ2 HER2-TAC T (4)
ACE2016 (2)
ACE1831 (0)
ADI-002 (0)
BTN2A1/3A1-Fc-CD19scFv (0)
CD7-UCAR-γδT cells (0)
CLN-619 (0)
CTM-N2D (0)
ECT204 (0)
ET 019003 (0)
ET-190 (0)
ET140203 (0)
ET1402L1-ARTEMIS T cells (0)
ET206 (0)
GDT002 (0)
Gamma delta T-cells (0)
ICT01 (0)
INB-100 (0)
INB-200 (0)
INB-300 (0)
autologous γδ T lymphocytes (0)
ALEXIS-ISO-1 (0)
LAVA-051 (0)
LYT-210 (0)
NK/γδ T cell-enriched cell therapy (0)
PF-08046052 (0)
QH104 (0)
TAK-012 (0)
UTAA06 (0)
anti-CD19-CAR γδT (0)
AVM0703 (0)
γδT Cell infusion (0)
γδT Cell infusion agent (0)
IMPT-314 (2)
MB-106 (1)
JNJ-4496 (1)
4SCAR-CD22/CD123/CD38/CD10/CD20/TSLPR (0)
4SCAR-T (0)
Anti-CD19/CD20/CD22 CAR T-Cells (0)
CAR-20/19-T Cells (0)
CAR-T CD19/CD20/CD22/CD30 (0)
CAR20.19.22 T (0)
CART20 (0)
CBM-C20.1 (0)
CD19/CD20 CAR T-cells (0)
CD20-CART (0)
CD20-CD19 cCAR T cells (0)
ELC-301 (0)
JNJ-9530 (0)
KITE-363 (0)
LCAR-AIO (0)
LY007 (0)
MB-CART20.1 (0)
PBCAR 20A (0)
RG6540 (0)
U16 (0)
UCART20x22 (0)
YTS101 (0)
autologous TriCAR T (0)
bbT369 (0)
multi-CAR-T cell therapy (0)
sequential different B cell antigen-targeted CAR T-cell therapy (0)
MB-CART2019.1 (0)
›
Associations
(1)
News
Trials
VERI cancer hierarchy
Reset Filters
CD20 expression
Lymphoma
CD20 expression
Lymphoma
ADI-001
Sensitive: C3 – Early Trials
ADI-001
Sensitive
:
C3
ADI-001
Sensitive: C3 – Early Trials
ADI-001
Sensitive
:
C3
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login